Table 1.
Clinical potential of miRNAs/lncRNAs in cHL.
| miRNA/ncRNA | Putative Role | Clinical Potential | References |
|---|---|---|---|
| 25-miRNA | OncomiR | Diagnostic biomarker | [72] |
| has-miR-21 | OncomiR | Prognostic biomarker | [73] |
| has-miR-30e/d | OncomiR | Prognostic biomarker | [73] |
| has-miR-92b | OncomiR | Prognostic biomarker | [73] |
| has-miR-124a | OncomiR | Prognostic biomarker | [74] |
| 18-lncRNA | Oncogene | Prognostic biomarker | [78] |
| FLJ42351 | Oncogene | Diagnostic biomarker | [75] |
| LINC00116 | Oncogene | Diagnostic biomarker | [76] |
| LINC00461 | Oncogene | Diagnostic biomarker | [76] |
| lncRNA H19 | Oncogene | Prognostic biomarker | [79] |